4DMedical (ASX:4DX) secured a deal with the University of Chicago Medicine for the use of its lung imaging products, according to a Monday filing with the Australian bourse.
The contract will allow the academic medical center access to the company's lung imaging suite of products, including its computed tomography-enabled lung ventilation analysis software, the filing said.
Financial terms were not disclosed.
4DMedical's shares gained 1% in recent Monday trade.
Price (AUD): $0.47, Change: $+0.01, Percent Change: +1.08%
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.